Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2
Authors:
- Pei-Ming YangPei-Ming Yang
- Yu-Fan ChangYCYu-Fan Chang
- Victor E. MarquezVMVictor E. Marquez
- Ching-Chow ChenCCChing-Chow Chen
- 1 February 2011
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 81 (4) , 510-517
Abstract
No abstract availableKeywords
Funding Information
- National Science Council of Taiwan
This publication has 48 references indexed in Scilit:
- Clinical Features of 5,628 Primary Lung Cancer PatientsChest, 2005
- Post-translational modification of p53 in tumorigenesisNature Reviews Cancer, 2004
- The effect of thalidomide on non-small cell lung cancer (NSCLC) cell lines: possible involvement in the PPAR pathwayCarcinogenesis, 2004
- EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cellsProceedings of the National Academy of Sciences of the United States of America, 2003
- The polycomb group protein EZH2 is involved in progression of prostate cancerNature, 2002
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- Chemotherapy for advanced non-small cell lung cancer: standardsLung Cancer, 2001
- p300/CBP‐mediated p53 acetylation is commonly induced by p53‐activating agents and inhibited by MDM2The EMBO Journal, 2001
- Synergistic activation of transcription by CBP and p53Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997